Yasuyuki Mitani

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Stem Cells From Human Exfoliated Deciduous Teeth as a Potent Cell Therapy for Radiation-Induced Osteonecrosis Model.

Stem Cells From Human Exfoliated Deciduous Teeth as a Potent Cell Therapy for Radiation-Induced Osteonecrosis Model.

Journal: Journal of orthopaedic research : official publication of the Orthopaedic Research Society

Published: February 07, 2026

Stem Cells from Human Exfoliated Deciduous Teeth Improve Motor Function after Sciatic Nerve Injury Through Suppression of Inflammation.

Stem Cells from Human Exfoliated Deciduous Teeth Improve Motor Function after Sciatic Nerve Injury Through Suppression of Inflammation.

Journal: Stem cells and development

Published: August 12, 2025

Novel stem cell therapy for cerebral palsy using stem cells from human exfoliated deciduous teeth.

Novel stem cell therapy for cerebral palsy using stem cells from human exfoliated deciduous teeth.

Journal: Stem cell research & therapy

Published: February 05, 2025

Migration Capacity of Stem Cells from Human Exfoliated Deciduous Teeth Towards Glioma.

Migration Capacity of Stem Cells from Human Exfoliated Deciduous Teeth Towards Glioma.

Journal: Journal of integrative neuroscience

Published: May 24, 2022

Potent bystander effect and tumor tropism in suicide gene therapy using stem cells from human exfoliated deciduous teeth.

Potent bystander effect and tumor tropism in suicide gene therapy using stem cells from human exfoliated deciduous teeth.

Journal: Cancer gene therapy

Published: December 18, 2021

Optimization and biological evaluation of imidazopyridine derivatives as a novel scaffold for γ-secretase modulators with oral efficacy against cognitive deficits in Alzheimer's disease model mice.

Optimization and biological evaluation of imidazopyridine derivatives as a novel scaffold for γ-secretase modulators with oral efficacy against cognitive deficits in Alzheimer's disease model mice.

Journal: Bioorganic & medicinal chemistry

Published: January 28, 2020

Discovery of N-ethylpyridine-2-carboxamide derivatives as a novel scaffold for orally active γ-secretase modulators.

Discovery of N-ethylpyridine-2-carboxamide derivatives as a novel scaffold for orally active γ-secretase modulators.

Journal: Bioorganic & medicinal chemistry

Published: July 29, 2019

Discovery of novel scaffolds for γ-secretase modulators without an arylimidazole moiety.

Discovery of novel scaffolds for γ-secretase modulators without an arylimidazole moiety.

Journal: Bioorganic & medicinal chemistry

Published: September 26, 2017

Pharmacological characterization of the novel γ-secretase modulator AS2715348, a potential therapy for Alzheimer's disease, in rodents and nonhuman primates.

Pharmacological characterization of the novel γ-secretase modulator AS2715348, a potential therapy for Alzheimer's disease, in rodents and nonhuman primates.

Journal: Neuropharmacology

Published: February 07, 2013

Amelioration of cognitive deficits in plaque-bearing Alzheimer's disease model mice through selective reduction of nascent soluble Aβ42 without affecting other Aβ pools.

Amelioration of cognitive deficits in plaque-bearing Alzheimer's disease model mice through selective reduction of nascent soluble Aβ42 without affecting other Aβ pools.

Journal: Journal of neurochemistry

Published: August 14, 2012

Differential effects between γ-secretase inhibitors and modulators on cognitive function in amyloid precursor protein-transgenic and nontransgenic mice.

Differential effects between γ-secretase inhibitors and modulators on cognitive function in amyloid precursor protein-transgenic and nontransgenic mice.

Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience

Published: February 11, 2012

Showing 1-11 of 11

Last Updated: 09/26/2026